Health insurer shares fall after UnitedHealth exec murder
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/21/2026
- Wall Street indexes fall, with Iran and earnings season in focus
- Oil settles 1% higher as hopes of renewed US-Iran negotiations offset Houthi threat
- Selloff of U.S. memory stocks creates a compelling entry point: analyst
- Why Moonshot AI's Kimi K3 is actually bullish for memory stocks
- AMC Entertainment soars on record quarterly results
- U.S. to impose 50% tariff on most Canadian goods, including USMCA
- NVIDIA reports 9.3% passive stake in Nebius
- Wall Street indexes fall, with Iran and earnings season in focus
- Cantor Fitzgerald Starts Trulieve Cannabis (TRLV) at Overweight, 'Purpose-Built for a New Cannabis Regulatory Framework'
- Selloff of U.S. memory stocks creates a compelling entry point: analyst
UnitedHealth Group (UNH) PT Lowered to $635 at Jefferies
December 9, 2024 8:03 AM ESTJefferies analyst David Windley lowered the price target on UnitedHealth Group (NYSE: UNH) to $635.00 (from $643.00) while maintaining a Buy rating.
The analyst comments "First, we express our deepest sympathies to Brian Thompson's family, colleagues, and friends. Respectfully moving to UNH, the 2025 guide of enterprise MLR +150bp implies MA at-risk MLR +220bp y/y. Part D growth, annualizing 2MR, and biz mix are headwinds. If (in the aftermath) efficacy of PA/UM are inhibited, low 60s% of total rev could be subject to mgn headwind. We still think low likelihood. We also start 2026 EPS... More
